Discover
RVMD
Revolution Medicines, Inc.
187.51
2 x 171.26
2 x 198.27
bid
ask
+
0.23
0.12%
2 @ 06:00 AM
189.24 +1.73 (0.92%)
| Ytd | 135.42% | |
| 1y | 404.19% |
182.82
day range
188.46
34.00
52 week range
193.09
| Open | 185.49 | Prev Close | 187.28 | Low | 182.82 | High | 188.46 | Mkt Cap | 39.86B |
| Vol | 2.08M | Avg Vol | 3.49M | EPS | -7.12 | P/E | N/A | Forward P/E | -32.99 |
| Beta | 1.41 | Short Ratio | 4.34 | Inst. Own | 95.85% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 153.70 | 200-d Avg | 100.67 | 1yr Est | 191.05 |
| Income Statement | |||
| Operating Expenses | 445.22M | ||
| Research and Development Expense | 343.97M | ||
| Selling, General and Administrative Expense | 101.25M | ||
| Operating Income | -445.22M | ||
| Interest Expense | 12.20M | ||
| Net Income | -453.82M | ||
| Net Income Common Stock | -453.82M | ||
| Net Income Common Stock (USD) | -453.82M | ||
| Consolidated Income | -453.82M | ||
| Earnings per Basic Share | -2.29 | ||
| Earnings per Basic Share (USD) | -2.29 | ||
| Earnings per Diluted Share | -2.29 | ||
| Earning Before Interest & Taxes (EBIT) | -441.62M | ||
| Earning Before Interest & Taxes (USD) | -441.62M | ||
| Weighted Average Shares | 198.10M | ||
| Weighted Average Shares Diluted | 198.10M | ||
| Balance Sheet | |||
| Cash and Equivalents | 445.80M | ||
| Cash and Equivalents (USD) | 445.80M | ||
| Investments | 1.50B | ||
| Investments Current | 1.47B | ||
| Investments Non-Current | 34.71M | ||
| Current Assets | 1.97B | ||
| Property, Plant & Equipment Net | 161.37M | ||
| Total Assets | 2.25B | ||
| Debt Current | 16.61M | ||
| Total Debt | 437.27M | ||
| Current Liabilities | 289.60M | ||
| Debt Non-Current | 420.66M | ||
| Total Liabilities | 753.82M | ||
| Accumulated Retained Earnings (Deficit) | -3.32B | ||
| Accumulated Other Comprehensive Income | -622.00K | ||
| Shareholders Equity | 1.50B | ||
| Shareholders Equity (USD) | 1.50B | ||
| Assets Non-Current | 285.82M | ||
| Total Debt (USD) | 437.27M | ||
| Goodwill and Intangible Assets | 70.41M | ||
| Liabilities Non-Current | 464.22M | ||
| Trade and Non-Trade Payables | 80.54M | ||
| Tax Liabilities | 2.35M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 4.54M | ||
| Net Cash Flow from Financing | 238.74M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 57.19M | ||
| Capital Expenditure | -1.54M | ||
| Issuance (Purchase) of Equity Shares | 238.94M | ||
| Net Cash Flow from Investing | 172.62M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 174.15M | ||
| Net Cash Flow from Operations | -354.16M | ||
| Share Based Compensation | 87.30M | ||